82 related articles for article (PubMed ID: 26359670)
1. Extreme Expression of DNA Repair Protein Apurinic/Apyrimidinic Endonuclease 1 (APE1) in Human Breast Cancer As Measured by Liquid Chromatography and Isotope Dilution Tandem Mass Spectrometry.
Coskun E; Jaruga P; Reddy PT; Dizdaroglu M
Biochemistry; 2015 Sep; 54(38):5787-90. PubMed ID: 26359670
[TBL] [Abstract][Full Text] [Related]
2. Identification and quantification of DNA repair protein poly(ADP ribose) polymerase 1 (PARP1) in human tissues and cultured cells by liquid chromatography/isotope-dilution tandem mass spectrometry.
Coskun E; Tuna G; Jaruga P; Tona A; Erdem O; Dizdaroglu M
DNA Repair (Amst); 2019 Mar; 75():48-59. PubMed ID: 30743082
[TBL] [Abstract][Full Text] [Related]
3. Identification and quantification of DNA repair protein apurinic/apyrimidinic endonuclease 1 (APE1) in human cells by liquid chromatography/isotope-dilution tandem mass spectrometry.
Kirkali G; Jaruga P; Reddy PT; Tona A; Nelson BC; Li M; Wilson DM; Dizdaroglu M
PLoS One; 2013; 8(7):e69894. PubMed ID: 23922845
[TBL] [Abstract][Full Text] [Related]
4. Addiction to MTH1 protein results in intense expression in human breast cancer tissue as measured by liquid chromatography-isotope-dilution tandem mass spectrometry.
Coskun E; Jaruga P; Jemth AS; Loseva O; Scanlan LD; Tona A; Lowenthal MS; Helleday T; Dizdaroglu M
DNA Repair (Amst); 2015 Sep; 33():101-10. PubMed ID: 26202347
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
Luo M; Kelley MR
Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
[TBL] [Abstract][Full Text] [Related]
6. Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers.
Poletto M; Di Loreto C; Marasco D; Poletto E; Puglisi F; Damante G; Tell G
Biochem Biophys Res Commun; 2012 Jul; 424(1):34-9. PubMed ID: 22713458
[TBL] [Abstract][Full Text] [Related]
7. Visualization and Comparison of the Level of Apurinic/Apyrimidinic Endonuclease 1 in Live Normal/Cancerous and Neuron Cells with a Fluorescent Nanoprobe.
Lu P; Cao X; Zheng J; Sun Y; Tang Z; Zhao M
Molecules; 2023 May; 28(9):. PubMed ID: 37175345
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in breast cancer.
Woo J; Park H; Sung SH; Moon BI; Suh H; Lim W
PLoS One; 2014; 9(6):e99528. PubMed ID: 24914806
[TBL] [Abstract][Full Text] [Related]
9. Receptor-based virtual screening and biological characterization of human apurinic/apyrimidinic endonuclease (Ape1) inhibitors.
Ruiz FM; Francis SM; Tintoré M; Ferreira R; Gil-Redondo R; Morreale A; Ortiz ÁR; Eritja R; Fàbrega C
ChemMedChem; 2012 Dec; 7(12):2168-78. PubMed ID: 23109358
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer.
Abdel-Fatah TM; Perry C; Moseley P; Johnson K; Arora A; Chan S; Ellis IO; Madhusudan S
Breast Cancer Res Treat; 2014 Feb; 143(3):411-21. PubMed ID: 24381055
[TBL] [Abstract][Full Text] [Related]
11. Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.
Antoniali G; Serra F; Lirussi L; Tanaka M; D'Ambrosio C; Zhang S; Radovic S; Dalla E; Ciani Y; Scaloni A; Li M; Piazza S; Tell G
Nat Commun; 2017 Oct; 8(1):797. PubMed ID: 28986522
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of 3-carbamoylbenzoic acid derivatives as inhibitors of human apurinic/apyrimidinic endonuclease 1 (APE1).
Aiello F; Shabaik Y; Esqueda A; Sanchez TW; Grande F; Garofalo A; Neamati N
ChemMedChem; 2012 Oct; 7(10):1825-39. PubMed ID: 22952012
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.
Zawahir Z; Dayam R; Deng J; Pereira C; Neamati N
J Med Chem; 2009 Jan; 52(1):20-32. PubMed ID: 19072053
[TBL] [Abstract][Full Text] [Related]
14. Structure-based virtual screening toward the discovery of novel inhibitors of the DNA repair activity of the human apurinic/apyrimidinic endonuclease 1.
Guerreiro PS; Estácio SG; Antunes F; Fernandes AS; Pinheiro PF; Costa JG; Castro M; Miranda JP; Guedes RC; Oliveira NG
Chem Biol Drug Des; 2016 Dec; 88(6):915-925. PubMed ID: 27450574
[TBL] [Abstract][Full Text] [Related]
15. Polyubiquitination of apurinic/apyrimidinic endonuclease 1 by Parkin.
Scott TL; Wicker CA; Suganya R; Dhar B; Pittman T; Horbinski C; Izumi T
Mol Carcinog; 2017 Feb; 56(2):325-336. PubMed ID: 27148961
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.
Poletto M; Malfatti MC; Dorjsuren D; Scognamiglio PL; Marasco D; Vascotto C; Jadhav A; Maloney DJ; Wilson DM; Simeonov A; Tell G
Mol Carcinog; 2016 May; 55(5):688-704. PubMed ID: 25865359
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of the DNA repair enzyme apurinic/apyrimidinic endonuclease 1 stimulates transforming growth factor-β1 production and promotes actin rearrangement.
Sakai Y; Yamamori T; Yasui H; Inanami O
Biochem Biophys Res Commun; 2015 May; 461(1):35-41. PubMed ID: 25858321
[TBL] [Abstract][Full Text] [Related]
18. Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-kappaB activation.
Wu HH; Cheng YW; Chang JT; Wu TC; Liu WS; Chen CY; Lee H
Oncogene; 2010 Jul; 29(30):4330-40. PubMed ID: 20498636
[TBL] [Abstract][Full Text] [Related]
19. A specific DNA-nanoprobe for tracking the activities of human apurinic/apyrimidinic endonuclease 1 in living cells.
Zhai J; Liu Y; Huang S; Fang S; Zhao M
Nucleic Acids Res; 2017 Apr; 45(6):e45. PubMed ID: 27923991
[TBL] [Abstract][Full Text] [Related]
20. DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.
Kaur G; Cholia RP; Mantha AK; Kumar R
J Med Chem; 2014 Dec; 57(24):10241-56. PubMed ID: 25280182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
